Genzyme rejects Sanofi-Aventis’ $18.5 billion offer

BOSTON (Reuters) – Genzyme Corp rejected an $18.5 billion takeover offer from French drugmaker Sanofi-Aventis, saying it dramatically undervalues the company.


Leave a Reply